U.S. federal trademark · Serial No. 90348702
Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer
Pharmaceutical research and development; pharmaceutical product evaluation; testing of pharmaceuticals; development of pharmaceutical preparations and medicines; and scientific research in the fields of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.